Names | |
---|---|
Preferred IUPAC name
3-{2-[Methyl(propyl)amino]ethyl}-1H-indol-4-ol | |
Identifiers | |
3D model (
JSmol)
|
|
ChemSpider | |
PubChem
CID
|
|
UNII | |
CompTox Dashboard (
EPA)
|
|
| |
| |
Properties | |
C14H20N2O | |
Molar mass | 232.327 g·mol−1 |
Except where otherwise noted, data are given for materials in their
standard state (at 25 °C [77 °F], 100 kPa).
|
4-Hydroxy-N-methyl-N-propyltryptamine, commonly known as 4-HO-MPT or meprocin, is a psychedelic drug in the tryptamine class of chemical compounds and is a higher homologue of the naturally occurring substituted tryptamine psilocin as well as being the 4- hydroxyl analog of MPT.
4-HO-MPT was first synthesized and bioassayed by biochemist Alexander Shulgin and written about in his 1994 book TiHKAL. [1]
For psychedelic effects, the dosage and duration are listed as "unknown" in TiHKAL. [1]
Very little data exists about the pharmacological properties, metabolism, and toxicity of 4-HO-MPT. In a single trial of 8 mg orally of 4-HO-MPT HCl from TiHKAL, it is described as producing visual distortion, vertigo, and slight insomnia. [1]
4-HO-MPT is not scheduled by the United Nations' Convention on Psychotropic Substances. [2]
4-HO-MPT is not scheduled at the federal level in the United States, [3] but it is possible that 4-HO-MPT could legally be considered an analog of psilocin, in which case, sales or possession with intent for human consumption could potentially be prosecuted under the Federal Analogue Act. [4]
Names | |
---|---|
Preferred IUPAC name
3-{2-[Methyl(propyl)amino]ethyl}-1H-indol-4-ol | |
Identifiers | |
3D model (
JSmol)
|
|
ChemSpider | |
PubChem
CID
|
|
UNII | |
CompTox Dashboard (
EPA)
|
|
| |
| |
Properties | |
C14H20N2O | |
Molar mass | 232.327 g·mol−1 |
Except where otherwise noted, data are given for materials in their
standard state (at 25 °C [77 °F], 100 kPa).
|
4-Hydroxy-N-methyl-N-propyltryptamine, commonly known as 4-HO-MPT or meprocin, is a psychedelic drug in the tryptamine class of chemical compounds and is a higher homologue of the naturally occurring substituted tryptamine psilocin as well as being the 4- hydroxyl analog of MPT.
4-HO-MPT was first synthesized and bioassayed by biochemist Alexander Shulgin and written about in his 1994 book TiHKAL. [1]
For psychedelic effects, the dosage and duration are listed as "unknown" in TiHKAL. [1]
Very little data exists about the pharmacological properties, metabolism, and toxicity of 4-HO-MPT. In a single trial of 8 mg orally of 4-HO-MPT HCl from TiHKAL, it is described as producing visual distortion, vertigo, and slight insomnia. [1]
4-HO-MPT is not scheduled by the United Nations' Convention on Psychotropic Substances. [2]
4-HO-MPT is not scheduled at the federal level in the United States, [3] but it is possible that 4-HO-MPT could legally be considered an analog of psilocin, in which case, sales or possession with intent for human consumption could potentially be prosecuted under the Federal Analogue Act. [4]